AbbVie Revenue and Competitors
Estimated Revenue & Valuation
- AbbVie's estimated annual revenue is currently $55.2B per year.
- AbbVie's estimated revenue per employee is $926,728
- AbbVie's total funding is $10.9M.
- AbbVie's current valuation is $240.2B. (January 2022)
Employee Data
- AbbVie has 59532 Employees.
- AbbVie grew their employee count by 5% last year.
AbbVie's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chairman the Board & CEO | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | Chief Equity Officer and VP People Experience | Reveal Email/Phone |
6 | Director, Chief Staff: Global Clinical Development Operations | Reveal Email/Phone |
7 | Director, Clinical Operations and Chief Staff | Reveal Email/Phone |
8 | Director, Business Management & Continuity (Chief Staff) | Reveal Email/Phone |
9 | Director Strategic Planning & Projects - Chief Staff | Reveal Email/Phone |
10 | Director, Strategy & Operations and Chief Staff | Reveal Email/Phone |
AbbVie Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $42310M | 219294 | 5% | N/A | $226.6B |
#2 | $305.3M | 1231 | 7% | $450M | N/A |
#3 | $69340M | 112676 | 4% | N/A | $308.4B |
#4 | $1967.7M | 14055 | -6% | N/A | N/A |
#5 | $25770M | 49142 | 10% | $68M | $132.6B |
What Is AbbVie?
AbbVieￃﾢ￢ﾂﾬ￢ﾄﾢs mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peopleￃﾢ￢ﾂﾬ￢ﾄﾢs lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womenￃﾢ￢ﾂﾬ￢ﾄﾢs health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Review our LinkedIn community guidelines at http://bit.ly/AbbVieSocialGuidelines
keywords:Biotechnology, Medical, Pharmaceuticals
$10.9M
Total Funding
59532
Number of Employees
$55.2B
Revenue (est)
5%
Employee Growth %
$240.2B
Valuation
N/A
Accelerator
AbbVie News
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ABBVie Inc. (NYSE: ABBV) between April 30,...
2022-04-18 | NYSE:ABBV) AbbVie Class Action: Levi & Korsinsky Reminds AbbVie Inc. Investors of the Pending Class Action Lawsuit with a Lead...
Shares of AbbVie Inc. shed 1.82% to $159.36 Monday, on what proved to be an all-around poor trading session for the stock market,...
NEW YORK, April 17, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm,...
AbbVie (ABBV) is a long- term holding that I pushed hard over the last year. See why I am reducing my ABBV share exposure and replacing it...
Other Companies in Chicago
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23670M | 65946 | 14% | $4.8M |
#2 | $15730.4M | 80257 | N/A | N/A |
#3 | $31152M | 90453 | 6% | N/A |
#4 | $62800M | 166717 | 8% | N/A |
#5 | $42310M | 219294 | 5% | N/A |